Extra Strength Gas Relief Tablet, Chewable
FDA Label NDC 69256-135

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Harris Teeter, Llc for the product Extra Strength Gas Relief (NDC 69256-135). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient(in each tablet), purpose, use(s), warnings, keep out of reach of children, directions, other information, inactive ingredients, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredient(In Each Tablet)

Simethicone 125 mg

Purpose

Anti-gas

Use(S)

relieves:

  • pressure
  • bloating
  • symptoms referred to as gas

Warnings

.

Keep Out Of Reach Of Children

In case of overdose, get medical help or contact a poison control center immediately.

Directions

  • adults and children 12 years and older: chew 1 to 2 tablets thoroughly as needed after meals and at bedtime
  • do not exceed 4 tablets in a 24 hour period except under the advice and supervision of  a physician.

Other Information

  • do not use if any individual blister unit is broken or open
  • store at room temperature
  • avoid high humidity and excessive heat, above 40°C (104°F)

Inactive Ingredients

D&C red # 30 aluminum lake, D&C yellow # 10 aluminum lake, dextrose, flavor, magnesium stearate, maltodextrin, microcrystalline cellulose, sorbitol, sucrose.

Principal Display Panel

Harris Teeter™

NDC 69256-135-73


EXSTRA STRENGTH

GAS RELIEF

Antigas. Simethicone 125 mg

 

Relieves: 

Pressure

Bloating

Gas Distress


Compare to the Active Ingredient in Gas-X® Extra Strength*


Mint Flavor 

 

18 chewable tablets

134-18-ht.jpg (134 18 Ht)

134-18-ht.jpg (134 18 Ht)

 


* Please review the disclaimer below.